Hospital 12 de Octubre, Madrid, Spain.
J Am Soc Nephrol. 2010 Apr;21(4):697-704. doi: 10.1681/ASN.2009080861. Epub 2010 Jan 28.
Spontaneous remission is a well known characteristic of idiopathic membranous nephropathy, but contemporary studies describing predictors of remission and long-term outcomes are lacking. We conducted a retrospective, multicenter cohort study of 328 patients with nephrotic syndrome resulting from idiopathic membranous nephropathy that initially received conservative therapy. Spontaneous remission occurred in 104 (32%) patients: proteinuria progressively declined after diagnosis until remission of disease at 14.7 +/- 11.4 months. Although spontaneous remission was more frequent with lower levels of baseline proteinuria, it also frequently occurred in patients with massive proteinuria: 26% among those with baseline proteinuria 8 to 12 g/24 h and 22% among those with proteinuria >12 g/24 h. Baseline serum creatinine and proteinuria, treatment with angiotensin-converting enzyme inhibitors or angiotensin receptor antagonists, and a >50% decline of proteinuria from baseline during the first year of follow-up were significant independent predictors for spontaneous remission. Only six patients (5.7%) experienced a relapse of nephrotic syndrome. The incidence of death and ESRD were significantly lower among patients with spontaneous remission. In conclusion, spontaneous remission is common among patients with nephrotic syndrome resulting from membranous nephropathy and carries a favorable long-term outcome with a low incidence of relapse. A decrease in proteinuria >50% from baseline during the first year predicts spontaneous remission.
自发缓解是特发性膜性肾病的一个显著特征,但目前缺乏描述缓解预测因素和长期结果的当代研究。我们对 328 例接受保守治疗的特发性膜性肾病肾病综合征患者进行了回顾性、多中心队列研究。104 例(32%)患者出现自发缓解:蛋白尿在诊断后逐渐下降,直至 14.7±11.4 个月时疾病缓解。尽管自发缓解在基线蛋白尿水平较低时更为常见,但在大量蛋白尿患者中也经常发生:基线蛋白尿为 8-12g/24h 的患者中占 26%,蛋白尿>12g/24h 的患者中占 22%。基线血清肌酐和蛋白尿、血管紧张素转换酶抑制剂或血管紧张素受体拮抗剂的治疗以及第一年随访期间蛋白尿较基线下降>50%是自发缓解的显著独立预测因素。仅有 6 例患者(5.7%)出现肾病综合征复发。自发缓解患者的死亡率和 ESRD 发生率显著较低。总之,膜性肾病肾病综合征患者自发缓解较为常见,长期预后良好,复发率低。第一年蛋白尿较基线下降>50%可预测自发缓解。